Lysosomal Therapeutics
Venture capital · Cambridge, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jun 29, 2026.Raises and exits come from each company’s own SEC and company records.
1Deep-tech portfolio0 active
1Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Prevail Therapeutics
6Co-investorsShare a portfolio company
Portfolio · 1 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Prevail Therapeutics | Biotech | Acquired | Mar 14, 2018 | $57.0M |
Peer ranks
Portfolio size#234
Portfolio exits#160
Raises, 12 months#88
Co-investors#188
Co-investors
- Biotechnology Value FundVenture capital1 shared
- F-Prime CapitalVenture capital1 shared
- Lilly VenturesVenture capital1 shared
- OrbiMedVenture capital1 shared
- RA CapitalVenture capital1 shared
- RegeneronVenture capital1 shared
Sectors
- Biotech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.